parinaric acid has been researched along with hydralazine in 1 studies
| Studies (parinaric acid) | Trials (parinaric acid) | Recent Studies (post-2010) (parinaric acid) | Studies (hydralazine) | Trials (hydralazine) | Recent Studies (post-2010) (hydralazine) |
|---|---|---|---|---|---|
| 223 | 0 | 11 | 4,580 | 364 | 393 |
| Protein | Taxonomy | parinaric acid (IC50) | hydralazine (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 1.265 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.649 | |
| Lactoperoxidase | Bos taurus (cattle) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heyliger, CE; Powell, DM; Skau, KA | 1 |
1 other study(ies) available for parinaric acid and hydralazine
| Article | Year |
|---|---|
Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus.
Topics: Animals; Antihypertensive Agents; Carrier Proteins; Diabetes Mellitus, Experimental; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids, Unsaturated; Hydralazine; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Myelin P2 Protein; Myocardium; Neoplasm Proteins; Nerve Tissue Proteins; Rats; Rats, Wistar; Streptozocin | 1995 |